Health Law Update

Home | Health Law Update

<img class="alignright wp-image-3603 size-medium" src="https://healthlawupdate.bakerhostetlerblogs.com/wp-content/uploads/sites/19/2016/04/science-iStock_000080822095_Full-198x300.jpg" alt="science iStock_000080822095_Full" width="198" height="300" />As the pace of biosimilars development picks up, many pharmaceutical companies are looking for guidance in understanding the patent and regulatory landscapes in the United States and in Europe. This seminar will provide practical advice on the most recent legal developments, preparing for biosimilar approval and patent and litigation strategies.

Our speakers from BakerHostetler and Carpmaels &amp; Ransford LLP have in-depth knowledge of the current state of play in the biologics and biosimilars field and will share their insights on best practices to find success in this rapidly developing area of the pharmaceutical industry.

<strong><a href="http://www.bakerlaw.com/events/biologics-and-biosimilars-in-the-us-and-europe">Register Now &gt;&gt;</a></strong>